Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Inovio Pharmaceuticals Inc (INO) vs Teradyne, Inc. (TER) Price & Performance

Inovio Pharmaceuticals IncTrade
Teradyne, Inc.Trade

Price performance (Past 24H)

Key statistics

Inovio Pharmaceuticals Inc vs Teradyne, Inc. — how do they compare? Inovio Pharmaceuticals Inc trades at $0.8 (market cap $78.55M), while Teradyne, Inc. trades at $388.87 (market cap $59.34B). The key difference: Teradyne, Inc. is far larger — about 755.4× Inovio Pharmaceuticals Inc's market cap, and Teradyne, Inc. pays a 0.14% dividend while Inovio Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.

INOTER
Market Cap
$78.55M$59.34B
Sector
HealthTechnology
52-Week High
$2.87$483.84
52-Week Low
$0.66$109.30
Enterprise Value
$49.56M$59.09B
Dividend Yield
0.14%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Inovio Pharmaceuticals Inc

Inovio Pharmaceuticals Inc is a United States based biotechnology company that develops active DNA-based immunotherapies and vaccines to treat and prevent cancers and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Read more on INO

About Teradyne, Inc.

Teradyne provides testing equipment, including automated test equipment for semiconductors, system testing for hard disk drives, circuit boards, and electronics systems and wireless testing for devices. The firm entered the industrial automation market in 2015, into which it sells collaborative and autonomous robots for factory applications. Teradyne serves numerous end markets and geographies directly and indirectly with its products, but its most significant exposure is to semiconductor testing, which made up 71% of 2021 sales. Teradyne serves vertically integrated, fabless, and foundry chipmakers with its equipment.

Read more on TER